PTAB Agrees To Review Allergan Restasis Patents
The Patent Trial and Appeal Board on Thursday agreed to review the asserted claims of six Allergan patents related to the dry eye treatment Restasis, finding Mylan has demonstrated that at...To view the full article, register now.
Already a subscriber? Click here to view full article